Personal information

Activities

Collapse all

Employment (1)

Max Delbrück Center for Molecular Medicine: Berlin, Berlin, Germany, DE

2023-09-04 to present | PhD Student (Mobile DNA Lab )
Employment
Source: Self-asserted source
José Andrés Espejo Oltra

Education and qualifications (2)

University of Bordeaux: Bordeaux, FR

2020 to 2022 | MSc in Neuroscience & Biotechnology (Science & Technology)
Education
Source: Self-asserted source
José Andrés Espejo Oltra

Universidad Católica de Valencia San Vicente Mártir Facultad de Veterinaria y Ciencias Experimentales: Valencia, Comunidad Valenciana, ES

2012 to 2019 | BSc in Biotechnology (Experimental Sciences)
Education
Source: Self-asserted source
José Andrés Espejo Oltra

Works (6)

Advancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Future Perspectives

Journal of Clinical Medicine
2024-01-06 | Journal article
DOI: 10.3390/jcm13020325
Contributors: Katharine A. Seton; José A. Espejo-Oltra; Karen Giménez-Orenga; Rik Haagmans; Donia J. Ramadan; Jesper Mehlsen
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Autoantibodies to Selenoprotein P in Patients with Chronic Fatigue Syndrome Suggest Selenium Transport Impairment and Acquired Resistance to Thyroid Hormone

SSRN Electronic Journal
2023 | Journal article
DOI: 10.2139/ssrn.4332223
Part of ISSN: 1556-5068
Contributors: Qian Sun; Elisa Oltra; D. A. Janneke Dijck-Brouwer; Thilo Samson Chillon; Petra Seemann; Sabrina Asaad; Kamil Demircan; José Andrés Espejo-Oltra; Teresa Sánchez-Fito; Eva Martin-Martinez et al.
Source: Self-asserted source
José Andrés Espejo Oltra

Improving Therapeutic Interventions of Schizophrenia with Advances in Stem Cell Technology.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
2020-08-01 | Journal article
DOI: 10.9758/cpn.2020.18.3.352
PMID: 32702214
PMC: PMC7383010
Source: Self-asserted source
José Andrés Espejo Oltra
grade
Preferred source (of 2)‎

Activation of Transposable Elements in Immune Cells of Fibromyalgia Patients.

International journal of molecular sciences
2020-02-18 | Journal article
Part of DOI: 10.3390/ijms21041366
Part of PMID: 32085571
Part of PMC: PMC7072917
Source: Self-asserted source
José Andrés Espejo Oltra

Epigenetic Components of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Uncover Potential Transposable Element Activation.

Clinical therapeutics
2019-03-23 | Journal article
Part of DOI: 10.1016/j.clinthera.2019.02.012
Part of PMID: 30910331
Source: Self-asserted source
José Andrés Espejo Oltra

Unraveling the Molecular Determinants of Manual Therapy: An Approach to Integrative Therapeutics for the Treatment of Fibromyalgia and Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

International journal of molecular sciences
2018-09-09 | Journal article
Part of DOI: 10.3390/ijms19092673
Part of PMID: 30205597
Part of PMC: PMC6164741
Source: Self-asserted source
José Andrés Espejo Oltra
How many people are using ORCID?